The Puncturable Atrial Septal Defect Occluder Trial (the PASSER Trial)
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 128 participants.
Also called NCT05371366
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 128 participants
- Sponsor
- Registry
-
NCT05371366
-
- Other papers using this trial's data
- Comparison of a Novel Occluder Versus Traditional Occluder in Atrial Septal Defect: A Randomized Trial
- Device endothelialization and morphology assessments at 1 year using computed tomography angiography: comparison of traditional with novel puncturable atrial septal defect occluders
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05371366. Randomized; no masking; primary purpose treatment. Start 2022-04-22 (actual); primary completion 2023-04-22 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Puncturable Atrial Septal Defect Occluder Trial (the PASSER Trial)
- Condition
- Atrial Septal Defect
- Intervention (Device)
- ASD closure with the novel occluder (ReAces)
- Intervention (Device)
- ASD closure with normal occluder
- Lead sponsor
- Shanghai Zhongshan Hospital
Record details
- Record id
cardio:ct-nct05371366- Content hash
c6feea3bac7084949875adb9bccbd7a35611c26d13f34e423980e013949eb45e